Method and apparatus for efficient stenosis identification in peripheral arterial vasculature using MR imaging

• US 6,408,201 B1
• Filed: 06/09/2000
• Issued: 06/18/2002
• Est. Priority Date: 06/09/2000
• Status: Expired due to Term

• Current Assignee: General Electric Company, Uniformed Services University of the Health Sciences (Government of the United States of America)
• Original Assignee: Defense United States Department of As Represented By The Secretary of Defense, General Electric Company, Uniformed Services University of the Health Sciences (Government of the United States of America)
• Inventors: Ho, Vincent B., Foo, Thomas K. F.
• Primary Examiner(s): Lateef, Marvin M.
• Assistant Examiner(s): Lin, Jeoyuh
• Application Number:
  US09/591,300
• Time in Patent Office: 739 Days
• Field of Search: 600/420, 600/407, 600/419, 600/410, 382/128, 324/300, 324/307
• US Class Current: 600/410
• CPC Class Codes: A61B 5/055 involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
• CPC Class Codes: A61B 5/704 Tables

Abstract

A method and apparatus is disclosed to initially screen a patient'"'"'s peripheral arterial vasculature for lesions, or stenotic vessels, using MR technology, and then grading the severity of any located stenosis. The invention includes tracking the passage of a contrast agent bolus through a patient, while acquiring a series of first MR images having low resolution. This initial examination uses flow sensitive bi-polar gradient waveforms with a gradient echo imaging pulse sequence to increase the sensitivity to lesion detectability. The bi-polar gradients generate a broad distribution of velocities in a large voxel. Relevant stenoses present in a voxel will result in intra-voxel flow dephasing in voxels immediate to and distal to the stenosis. After identifying a stenosis, a second MR image, having a higher resolution than the first, is used to grade the stenosis.

Claims

1. A method of identifying a stenotic vessel in a patient'"'"'s peripheral arterial vasculature using MR imaging comprising the steps of:

performing a screening study by acquiring a series of first MR images having low spatial resolution along the patient'"'"'s peripheral arterial vasculature as a contrast bolus passes therethrough;

scanning the series of first MR images to identify a stenosis in the patient'"'"'s peripheral arterial vasculature; and

performing a detailed study by acquiring at least one second MR image having higher resolution than the series of first MR images for grading the identified stenosis.

2. The method of claim 1 wherein each first MR image is acquired using a flow sensitive three-dimensional fast imaging pulse sequence.

3. The method of claim 2 wherein the flow sensitive three-dimensional fast imaging pulse sequence includes bi-polar gradients in three directions to provide insensitivity to orientation of the vessel and any stenosis.

4. The method of claim 3 further comprising the step of initially setting a velocity encoding (VENC) value of a first moment of the flow-sensitizing bi-polar gradient to a nominally low value to establish a velocity distribution geater than 2π

within each voxel.

5. The method of claim 1 further comprising the step of applying a pulse sequence with flow-sensitizing bi-polar gradient in one direction when imaging a distal peripheral vasculature where flow is predominantly in a cranial-caudal direction.

6. The method of claim 1 wherein the series of first MR images provides high sensitivity to lesion detection in a blood vessel and wherein the step of scanning the series of first MR images includes detecting flow voids as an indication of a suspected stenosis.

7. The method of claim 1 further comprising the step of conditioning the acquisition of a second MR image upon identification of a stenosis in the step of screening the series of first MR images.

8. The method of claim 1 wherein the series of first MR images are acquired with high phase cancellation using at least one of:

(1) applying a pulse sequence with bi-polar gradients to accentuate phase cancellation; and

(2) increasing voxel size for greater distribution of velocity vectors;

to thereby increase flow dephasing.

9. The method of claim 1 wherein the second MR image is acquired with low phase cancellation and high resolution in order to isolate and grade the stenosis by at least one of:

(1) comparing diameters of the blood vessel along a length of the suspected stenosis;

(2) comparing a velocity gradient along the length of the stenosis; and

(3) measuring blood flow along the suspected stenosis.

10. The method of claim 1 further comprising the step of tracking passage of a contrast bolus that includes:

passing a test bolus through the patient'"'"'s peripheral vasculature;

tracking the test bolus through the patient'"'"'s peripheral vasculature;

determining a travel time that the test bolus takes to travel through a desired portion of the patient'"'"'s peripheral vasculature;

passing an exam bolus through the patient'"'"'s peripheral vasculature at a flow rate; and

using the test bolus travel time to track the passage of the exam bolus through the patient'"'"'s peripheral vasculature.

11. The method of claim 10 further comprising the steps of:

defining a given number of scan stations, each scan station positioned along a patient'"'"'s peripheral vasculature;

initially injecting a relatively small amount of contrast agent into a patient to pass the test bolus through the patient'"'"'s peripheral vasculature; and

adjusting the patient fore and aft with respect to an MR imaging device to position the patient such that a desired scan station is within a field-of-view of the MR imaging device based on the passage of the test bolus.

12. The method of claim 1 wherein the step of grading the stenosis includes determining peak flow velocity across the stenosis by:

applying a real-time phase contrast imaging pulse sequence to the vessel to allow user control of a flow encoding gradient value when acquiring the second MR image; and

determining peak flow velocity across the stenosis by correlating the flow encoding gradient value to an onset of flow velocity aliasing.

13. The method of claim 12 wherein the real-time phase contrast imaging pulse sequence has flow sensitizing gradients that are relatively coincident in time to allow a user to rotate flow sensitizing gradients in real-time.

14. The method of claim 12 further comprising the step of increasing an amplitude of the flow encoding gradient value until flow-related aliasing is detected.

15. The method of claim 12 further comprising the step of applying flow sensitizing gradient in three directions to provide insensitivity to vessel orientation.

16. The method of claim 1 wherein the step of grading the stenosis comprises:

identifying a first location of a suspected stenosis;

applying a phase contrast MR imaging pulse sequence to the first location of the suspected stenosis, the pulse sequence having a real-time user-controlled VENC value;

increasing the real-time user-controlled VENC value and reapplying the pulse sequence until a user observes flow-related aliasing;

recording the real-time user-controlled VENC value as an indication of peak flow velocity across the first location of the suspected stenosis;

resetting the real-time user-controlled VENC value;

applying the pulse sequence to a second location of the suspected stenosis;

increasing the real-time user-controlled VENC value and reapplying the pulse sequence until the user observes flow-related aliasing;

recording the real-time user-controlled VENC value as an indication of peak flow velocity across the second location of the suspected stenosis; and

comparing the real-time user-controlled VENC value of the first location with that of the second location to determine severity of the suspected stenosis.

17. The method of claim 15 wherein the phase contrast MR imaging pulse sequence is a 2D fast gradient echo pulse sequence having flow sensitizing bi-polar gradient waveforms that are relatively coincident in time.

18. The method of claim 15 wherein the step of increasing the real-time user-controlled VENC value is further defined as increasing an amplitude of a velocity encoding gradient until the VENC value corresponds to a peak flow velocity to thereby identify severity of the suspected stenosis.

20. The method of claim 18 further comprising the steps of:

passing a contrast bolus through the patient'"'"'s peripheral arterial vasculature and acquiring MR images coincident with the passage of the contrast bolus through the patient'"'"'s peripheral arterial vasculature.

22. The method of claim 18 further comprising the step of assessing severity of the steno sis by measuring a VENC value in real-time coincident with an onset of complete intra-voxel flow dephasing.

23. The method of claim 18 further comprising the step of assessing severity of the stenosis by measuring a VENC value in real-time coincident with an onset of flow related aliasing in a stenotic vessel.

24. The method of claim 18 wherein the series of first MR images are low resolution images with high sensitivity to velocity flow for detecting blood vessel lesions.

25. The method of claim 23 wherein the step of detecting a blood vessel lesion includes detecting velocity flow voids in the series of first MR images.

26. The method of claim 18 wherein the series of first MR images are acquired with high phase cancellation to increase flow dephasing using at least one of:

(1) applying a pulse sequence with bi-polar gradients to accentuate phase cancellation; and

(2) increasing voxel size for greater distribution of velocity vectors.

27. The method of claim 18 wherein the second MR image is acquired to grade the suspected stenosis by at least one of:

(1) comparing diameters of the blood vessel along a length of the suspected stenosis; and

(2) comparing a velocity gradient along the length of the suspected stenosis.

19. An examination method to identify a lesion in a patient'"'"'s peripheral arterial vasculature and grade a stenosis resulting therefrom comprising the step of:

injecting a contrast agent in a patient;

acquiring a series of first MR images using a gradient echo imaging pulse sequence having a flow sensitizing bi-polar gradient waveform across a patient'"'"'s peripheral arterial vasculature;

detecting and localizing a suspected stenosis using the series of first MR images;

if a stenosis is detected and localized, acquiring at least one second MR image having a higher resolution than the series of first MR images in a region in which the suspected stenosis is detected and localized to grade the suspected stenosis; and

if a stenosis is not detected and localized in the step detecting and localizing, ending the examination method without further MR image acquisition.

21. The method of claim 19 further comprising the steps of defining multiple stations to acquire the series of first MR images therein, and precisely moving to a next station using one of:

(1) contrast agent arrival monitoring, and

(2) pre-calculating bolus travel times.

28. An MRI apparatus to conduct MR stenosis screening, and if necessary, grade a stenotic vessel comprising:

a magnetic resonance imaging (MRI) system having a plurality of gradient coils positioned about a bore of a magnet to impress a polarizing magnetic field and an RF transceiver system and an RF switch controlled by a pulse module to transmit RF signals to an RF coil assembly to acquire MR images; and

a computer programmed to operate the MRI system in two modes to efficiently conduct a stenosis exam across a patient'"'"'s peripheral arterial vasculature,

the first mode programmed to;

track passage of a contrast bolus through the patient'"'"'s peripheral arterial vasculature;

acquire a series of first MR images with low resolution over the patient'"'"'s peripheral arterial vasculature;

receive input to either end the stenosis exam or switch to a second mode if a stenosis is indicated in the series of first MR images;

the second mode programmed to;

localize a field-of-view to target the stenosis; and

acquire at least one second MR image with resolution higher than that of the series of first MR images of the localized field-of-view to assess a severity of the stenosis.

29. The MRI apparatus of claim 28 wherein the computer is further programmed to:

use a first pulse sequence for the acquisition of the series of first MR images, the first pulse sequence having a flow-sensitizing bi-polar gradient waveform and a VENC value of a first moment of the flow sensitizing bi-polar gradient waveform set to a nominally low value; and

use a second pulse sequence for the acquisition of the at least one second MR image, the second pulse sequence providing less phase cancellation than the first pulse sequence and having a VENC value set substantially higher than the VENC value of the first pulse sequence.

30. The MRI apparatus of claim 28 wherein an encoded velocity distribution is greater than 2π

within each voxel in the series of first MR images.

31. The MRI apparatus of claim 28 wherein the acquisition of the at least one second MR image includes:

(a) applying a real-time phase contrast pulse sequence to a suspected stenotic vessel, where the pulse sequence has flow sensitizing gradients that are relatively coincident in time;

(b) allowing a user to adjust a VENC value of a velocity encoding gradient;

(c) applying the pulse sequence with the VENC value as adjusted by the user;

(d) determining whether flow-related aliasing is evident; and

(e) repeating acts (b) through (d) until the VENC value provides determinable flow-related aliasing that thus corresponds to a peak flow velocity across the suspected stenosis.

32. The apparatus of claim 31 wherein the computer is further programmed to increase an amplitude of the VENC value until flow-related aliasing is observable.

33. The MRI apparatus of claim 28 wherein the computer is further programmed to:

pass a test bolus through the patient'"'"'s peripheral vasculature;

track the test bolus through the patient'"'"'s peripheral vasculature;

determine a travel time that the test bolus takes to travel through a desired portion of the patient'"'"'s peripheral vasculature;

pass an exam bolus through the patient'"'"'s peripheral vasculature at a flow rate; and

use the test bolus travel time to track the passage of the exam bolus through the patient'"'"'s peripheral vasculature.

34. The MRI apparatus of claim 28 wherein the computer is further programmed to:

(a) ensure placement of a patient table within the MRI apparatus and within a first scan station of a given number of scan stations;

(b) upon an indication that a test bolus has entered a given scan station, track the test bolus through the given scan station;

(c) record a travel time of the test bolus through the first scan station;

(d) initiate patient table movement to a subsequent scan station;

(e) repeat (b), (c) and (d) for each subsequent scan station;

(f) return the patient table to the first scan station; and

(g) upon an indication that an exam bolus has been injected into the patient, activate the MRI apparatus to acquire at least central k-space MRI data of the patient within each scan station for each test bolus travel time as previously recorded for that scan station.

35. A computer readable storage medium having stored thereon a computer program comprising instructions which, when executed by a computer, cause the computer to:

acquire a series of first MR images of a patient'"'"'s peripheral arterial vasculature, the first MR image having high phase cancellation to screen a patient for possible arterial lesions, each first MR image in the series of first MR images is acquired within a scan station as a contrast bolus travels therethrough; and

limit a FOV to a target region within the patient'"'"'s peripheral arterial vasculature if a lesion is located therein, then

acquire a second MR image of the targeted region, the second MR image having a resolution higher than that of the first MR image.

36. The computer readable storage medium of claim 35 wherein the series of first MR images are acquired with high phase cancellation to increase flow dephasing using at least one of:

(1) applying a pulse sequence with bi-polar gradients to accentuate phase cancellation; and

(2) increasing voxel size for greater distribution of velocity vectors.

37. The computer readable storage medium of claim 35 wherein the computer is further programmed to:

use a first pulse sequence for the acquisition of the series of first MR images, the first pulse sequence having a flow-sensitizing bi-polar gradient waveform; and

use a second pulse sequence for the acquisition of the at least one second MR image, the second pulse sequence providing less phase cancellation than the first pulse sequence.

38. The computer readable storage medium of claim 35 wherein the computer is further programmed to:

apply a pulse sequence with at least one flow-sensitizing bi-polar gradient;

initially set a velocity encoding (VENC) value of a first moment of the at least one flow-sensitizing bi-polar gradient to a nominally low value to establish a velocity distribution greater than 2π

within each voxel; and

detect velocity flow voids in the series of first MR images as an indication of any lesions.

39. The computer readable storage medium of claim 35 wherein the computer is further programmed to acquire the second MR image with low phase cancellation and high resolution in order to isolate and grade the suspected stenosis by at least one of:

(1) comparing diameters of the blood vessel along a length of the suspected stenosis; and

(2) comparing a velocity gradient along the length of the suspected stenosis.

40. The computer readable storage medium of claim 35 wherein the computer is further programmed to acquire the second MR image by:

applying a real-time phase contrast imaging pulse sequence to the vessel to allow user control of a flow encoding gradient value when acquiring the second MR image; and

determining peak flow velocity across the stenosis by correlating the flow encoding gradient value to an onset of flow velocity aliasing.

41. The computer readable storage medium of claim 40 wherein the real-time phase contrast imaging pulse sequence has flow sensitizing gradients that are relatively coincident in time to allow a user to rotate flow sensitizing gradients in real-time.

42. The computer readable storage medium of claim 40 wherein the computer is further programmed to increase an amplitude of the flow encoding gradient value until flow related aliasing is detected.

43. The computer readable storage medium of claim 40 having stored thereon a computer program comprising instructions which, when executed by a computer, cause the computer to grade the stenosis by:

identifying a first location of a suspected stenosis;

applying a phase contrast MR imaging pulse sequence to the first location of the suspected stenosis, the pulse sequence having a real-time user-controlled VENC value;

increasing the real-time user-controlled VENC value and reapplying the pulse sequence until a user observes flow-related aliasing;

recording the real-time user-controlled VENC value as an indication of peak flow velocity across the first location of the suspected stenosis;

resetting the real-time user-controlled VENC value;

applying the pulse sequence to a second location of the suspected stenosis;

increasing the real-time user-controlled VENC value and reapplying the pulse sequence until the user observes flow-related aliasing;

recording the real-time user-controlled VENC value as an indication of peak flow velocity across the second location of the suspected stenosis; and

comparing the real-time user-controlled VENC value of the first location with that of the second location to determine severity of the suspected stenosis.

44. The computer readable storage medium of claim 40 wherein the computer is further programmed to track the contrast bolus through the patient'"'"'s peripheral arterial vasculature by:

passing a test bolus through the patient'"'"'s peripheral vasculature;

tracking the test bolus through the patient'"'"'s peripheral vasculature;

determining a travel time that the test bolus takes to travel through a desired portion of the patient'"'"'s peripheral vasculature;

passing an exam bolus through the patient'"'"'s peripheral vasculature at a flow rate; and

using the test bolus travel time to track the passage of the exam bolus through the patient'"'"'s peripheral vasculature.